Bluejay Diagnostics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2022 Annual Meeting of Stockholders held by Bluejay Diagnostics, Inc. on June 9, 2022. The company is an emerging growth company incorporated in Delaware, with its common stock (BJDX) trading on The NASDAQ Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Voting Results
As of the record date (April 29, 2022), there were 20,151,244 shares of common stock outstanding. A quorum was established with 12,494,263 shares (62.0%) present in person or by proxy. The following proposals were approved:
- Proposal 1: Election of Directors - Stockholders elected Douglas Wurth, Neil Dey, Svetlana Dey, Donald Chase, Fred Zeidman, and Gary Gemignani to serve until the 2023 Annual Meeting. All directors received significant majority support, with votes withheld ranging from approximately 76,000 to 130,704 per director.
- Proposal 2: Ratification of Auditors - Stockholders ratified the appointment of Wolf & Company, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2022. The vote was 12,396,085 for, 41,990 against, and 56,188 abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on business outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the tenure of the newly elected board members, specifically noting their terms expire at the 2023 Annual Meeting.
- Confirm the appointment of Wolf & Company, P.C. as the auditor for the fiscal year ending December 31, 2022.
- Note the high level of shareholder participation (62.0%) and the strong approval margins for both director elections and auditor ratification.
- Review the company's most recent 10-K or 10-Q filings for financial data, as this 8-K contains no financial metrics.